FDA Warning Letter — Opto-Pharm Pte Ltd.
The FDA took a Warning Letter action against Opto-Pharm Pte Ltd. on Mar 17, 2017 (Singapore, Singapore). The action was issued by CDER and concerns drugs products. This facility has 4 recent FDA inspections on record.
Action Details
- Facility
- Opto-Pharm Pte Ltd.
- Date
- Mar 17, 2017
- Fiscal Year
- 2017
- Product Type
- Drugs
- Center
- CDER
- Location
- Singapore (Singapore)